Dec 9 (Reuters) - CVS Health (CVS) on Tuesday forecast 2026 profit above Wall Street estimates and this year's projected earnings, signalling steady progress in the health conglomerate's turnaround plan.
CVS stock rose 5% in early trading on Tuesday.
The company in October projected double-digit earnings growth for 2026 after raising its 2025 profit forecast for the third time.
"We are closing out 2025 with meaningful momentum across our businesses and we expect another year of strong earnings growth in 2026," said Chief Financial Officer Brian Newman on Tuesday.
The company forecast 2026 adjusted profit to be in the range of $7.00 to $7.20 per share, compared with analysts' average estimate of $7.16, according to data compiled by LSEG.
It, however, expects total revenue of at least $400 billion next year, below analysts' average estimate of $419.26 billion.
CVS also raised its 2025 adjusted profit forecast to $6.60 to $6.70 per share from $6.55 to $6.65 previously.
(Reporting by Sneha S K in Bengaluru; Editing by Shinjini Ganguli)
LATEST POSTS
- 1
The Best Computer games Ever - 2RFK Jr. releases new dietary guidelines with emphasis on protein, full-fat dairy
- 3Web designers for Independent ventures
- 4College students are now slightly less likely to experience severe depression, research shows – but the mental health crisis is far from over
- 5Finding the Universe of Computer generated Reality: Individual Encounters
- Investigate Business Mastercard Choices for Better Rewards and Rewards
- How Mars' ancient lakes grew shields of ice to stay warm as the Red Planet froze
- The Development of Shipping: Controlling Towards a More Associated Future
- How to see the Ursids, the final meteor shower of 2025
- Bowen Yang is reportedly leaving 'Saturday Night Live' after this week's episode
- The Iconic, Instantly Recognizable Plastic Chair That's Known All Around The World
- 'Euphoria' Season 3 trailer includes Eric Dane's final appearance, Jacob Elordi and Sydney Sweeney at the altar and Rue's 'Breaking Bad' era
- As infant botulism cases climb to 31, recalled ByHeart baby formula is still on some store shelves
- Mom finds out she has cancer after noticing something was off while breastfeeding
